Purchase Order HT001417P0625
Award Date 9/28/17
Potential Completion Date 9/30/18
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order for $124,815.00 was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract is for the delivery of SC05 Sulfur Colloid 5 vials/box to support nuclear medicine diagnostic services for active duty personnel and their families within the Military Health System. Pharmalucence, Inc. has been awarded multiple...
- This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Pharmalucence, Inc., a for-profit manufacturer of pharmaceutical goods and medical supplies, for the delivery of radiopharmaceutical supplies, specifically sulfur colloid. The contract has a potential value of $162,030 and a period of performance ending on September 30, 2018. This award does not have a set-aside designation. Pharmalucence is an international, integrated, specialty pharmaceutical...
- The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call contract to Pharmalucence, Inc. for radiopharmaceuticals and supplies valued at $40,878.40, with an ultimate completion date of September 30, 2025. The contract, awarded on October 1, 2024, will be performed at Fort Bliss, Texas and carries no set-aside designation, indicating open competition. Pharmalucence, Inc., a specialty pharmaceutical manufacturer registered in SAM.gov since 2001, specializes in...
- This is a firm fixed-price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc. for the supply of various radiopharmaceuticals. The $100,000.00 contract has an ultimate completion date of September 30, 2025 and does not have a set-aside designation. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply and delivery of radiopharmaceutical kits. The contract has a ceiling value of $30,660.00 and a period of performance through June 2, 2025. The radiopharmaceutical kits include Mebrofenin, Sulfur Colloid, Medronate, Sestamibi, Mertiatide, and Ultratag RBC, which are used in nuclear medicine imaging procedures. This award is not set...
- The Defense Health Agency awarded a $187,899.40 firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on October 1, 2025, with completion targeted for September 30, 2026. This contract provides radiopharmaceuticals to support the Department of Radiology and Nuclear Medicine Clinic at Joint Base San Antonio Fort Sam Houston in Texas. No set-aside designation was applied to this award. Sofie CO., a for-profit subsidiary of Sofie Biosciences headquartered in Sterling,...
- This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The contract is for the provision of radiopharmaceuticals, including specialized nuclear medicine products such as Ga-68 Dotatate, iodine I-123, and technetium-99m, which are used in diagnostic imaging and cancer treatment procedures for veterans and military personnel. The...
- The Defense Health Agency awarded a $58,006.25 firm fixed-price purchase order to RLS (USA) Inc. for radiopharmaceuticals and related services to support the Department of Radiology Nuclear Medicine. The contract, awarded on October 1, 2025, with an ultimate completion date of September 30, 2026, represents a non-set-aside procurement for time-sensitive medical isotopes and diagnostic imaging agents required for nuclear medicine procedures at military treatment facilities. RLS (USA) Inc., a...
- This is a federal delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in radiopharmaceutical supplies. The contract, valued at $215,958.40, is for the provision of general radiopharmaceuticals to support nuclear medicine imaging procedures within the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in the northeastern United States. The contract is a firm fixed-price...